bacteri
mening
lifethreaten
diseas
predominantli
caus
streptococcu
pneumonia
neisseria
meningitidi
haemophilu
influenza
type
b
hib
children
adult
escherichia
coli
neonat
bloodborn
bacteria
invad
infect
brain
tissu
result
sever
inflammatori
respons
brain
parenchyma
mening
iovino
et
al
current
prevent
therapeut
strategi
includ
antibiot
vaccin
substanti
improv
clinic
outcom
bacteri
mening
diseas
still
repres
signific
threat
highlight
emerg
resist
bacteri
strain
rise
nonvaccin
type
strain
doran
et
al
diseas
burden
vari
geograph
region
prognosi
depend
avail
health
care
effici
vaccin
program
grandgirard
leib
survivor
bacteri
mening
often
suffer
neurolog
damag
hear
loss
motor
cognit
impair
larg
caus
host
inflammatori
respons
result
physic
impair
often
improv
time
cognit
declin
persist
lifelong
especi
pediatr
case
due
sensit
develop
brain
hoogman
et
al
grandgirard
leib
sever
mechan
involv
intrins
virul
factor
bacteria
host
defens
facilit
brain
invas
tissu
injuri
gerber
nau
doran
et
al
iovino
et
al
microgli
cell
abund
wellstudi
myeloid
popul
central
nervou
system
cn
ontogenet
distinct
hematopoiet
stem
cell
deriv
brain
macrophag
aris
earlier
embryon
stage
yolk
sac
progenitor
prinz
priller
microglia
resid
brain
parenchyma
consid
immun
sentinel
brain
greter
et
al
michel
et
al
barichello
et
al
bacteria
gain
access
brain
breach
bloodbrain
barrier
bbb
bacteri
product
lipopolysaccharid
gramneg
bacteria
lipoteicho
acid
gramposit
bacteria
recogn
pattern
recognit
receptor
prr
microglia
doran
et
al
iovino
et
al
exampl
receptor
express
microglia
involv
evok
inflammatori
respons
via
damag
signal
deriv
injur
host
cell
purinerg
receptor
tachykinin
receptor
estrogen
receptor
er
cannabinoid
receptor
cb
stella
burmeist
et
al
tohidpour
et
al
lee
et
al
microglia
also
serv
antigen
present
cell
bacteri
process
mhc
class
ii
upregul
togeth
astrocyt
microglia
repres
primari
sourc
complement
brain
almolda
et
al
veerhui
et
al
upon
activ
microglia
undergo
morpholog
chang
draw
long
ramif
associ
surveil
function
obtain
larger
amoeboid
shape
kettenmann
et
al
iovino
et
al
reactiv
state
microglia
releas
array
solubl
factor
exhibit
migratori
prolif
phagocyt
properti
adjust
type
activ
stimuli
reactiv
microglia
divid
polar
state
classic
activ
phenotyp
character
releas
proinflammatori
factor
altern
activ
associ
enhanc
phagocytosi
releas
antiinflammatori
neurotroph
factor
cherri
et
al
orihuela
et
al
howev
dichotom
classif
consid
oversimplifi
microglia
exist
spectrum
function
phenotyp
sousa
et
al
accur
framework
classifi
microgli
phenotyp
state
healthi
diseas
development
stage
remain
agre
upon
ransohoff
holtman
et
al
releas
proinflammatori
cytokin
tumor
necrosi
factor
tnf
interleukin
il
chemokin
lead
increas
permeabl
brain
microvascular
endothelium
upregul
adhes
molecul
facilit
leukocyt
recruit
brain
gerber
nau
mookkanamori
et
al
coutinho
et
al
tohidpour
et
al
activ
microglia
contribut
leakag
breakdown
bbb
produc
reactiv
oxygen
nitrogen
speci
matrix
metalloproteas
mmp
da
fonseca
et
al
increas
intracrani
pressur
selfamplifi
inflammatori
environ
ultim
result
respiratori
burst
neuron
cell
death
coutinho
et
al
doran
et
al
microgli
activ
particular
skew
respons
hallmark
neuroinflamm
thu
microglia
fundament
player
pathophysiolog
bacteri
mening
latest
year
extens
effort
put
scrutin
molecular
mechan
microgli
respons
brain
pathogen
hand
therapeut
strategi
discov
evalu
experiment
set
barichello
et
al
attract
target
manipul
microgli
respons
includ
modul
phenotyp
switch
toward
enhanc
phagocyt
function
block
proinflammatori
mediat
promot
releas
neurotroph
factor
protect
bbb
integr
hu
et
al
discuss
recent
advanc
made
understand
microglia
react
bacteria
vice
versa
potenti
implic
improv
therapeut
strategi
patient
deriv
postmortem
brain
biopsi
provid
valuabl
insight
pathophysiolog
bacteri
mening
repres
fatal
diseas
iovino
et
al
past
year
sever
vivo
model
develop
includ
mice
rat
rabbit
model
inocul
bacteria
either
intranas
intraven
intrathec
rout
koedel
pfister
hoogland
et
al
iovino
et
al
diseas
develop
usual
monitor
clinic
score
symptom
cerebrospin
fluid
csf
diagnosi
pathogen
inocul
cisterna
magna
csf
sampl
readili
perform
rabbit
rat
mice
due
larger
size
paul
et
al
howev
mous
model
repres
advantag
reflect
avail
genet
modifi
model
biolog
reagent
studi
relev
pathway
sever
vitro
model
microglia
exist
studi
microglia
characterist
includ
immort
cell
line
murin
hapi
rat
human
dello
russo
et
al
timmerman
et
al
primari
cultur
freshli
isol
microglia
stem
cellderiv
microglia
repres
better
biolog
model
cell
line
mimick
normal
physiolog
microglia
timmerman
et
al
ex
vivo
microgli
respons
studi
use
organotyp
slice
cultur
mice
hamster
rat
nonhuman
primat
czapiga
colton
burmeist
et
al
microglia
display
broad
spectrum
differ
phenotyp
involv
differ
function
sensit
chang
neural
environ
adjust
accordingli
henc
transcriptom
signatur
chang
dramat
day
cultur
outsid
normal
physiolog
nich
repres
challeng
especi
studi
compar
homeostat
state
microglia
galatro
et
al
moreov
establish
protocol
microgli
isol
cell
sort
report
lead
artifact
downstream
analysi
contamin
ingest
materi
surround
induct
activ
signatur
ribotag
translatom
profil
recent
develop
techniqu
gene
express
analysi
suggest
limit
artifact
improv
accuraci
studi
function
state
microglia
haimon
et
al
major
studi
microgli
respons
peripher
inflammatori
stimuli
direct
bacteri
stimuli
conduct
mice
wherea
activ
determin
measur
ioniz
calciumbind
adapt
molecul
tolllik
receptor
tlr
surfac
express
mrna
protein
level
hoogland
et
al
addit
use
knockout
mice
experiment
mening
defici
key
cytokin
adhes
molecul
proteas
contribut
complet
understand
involv
inflammatori
pathway
step
may
target
therapeut
purpos
paul
et
al
recent
difficult
distinguish
microglia
relat
myeloid
cell
due
larg
overlap
genet
signatur
surfac
marker
first
marker
discov
exclus
express
microglia
healthi
diseas
state
mice
human
open
new
venu
microglia
research
bennett
et
al
potenti
microgliaspecif
marker
discov
recent
transcriptom
profil
includ
siglech
olfactomedinlik
colonna
butovski
holtman
et
al
transgen
mice
gfp
label
microglia
promot
fractalkin
receptor
gener
excel
tool
imag
healthi
brain
less
use
studi
diseas
state
sinc
fractalkin
receptor
express
peripher
deriv
cell
present
brain
patholog
condit
jung
et
al
hirasawa
et
al
likewis
deplet
microglia
challeng
partial
complet
erad
microglia
cell
peripher
deriv
monocyt
serv
microglia
progenitor
repopul
brain
shortli
deplet
lund
et
al
sustain
microglia
deplet
achiev
continu
pharmacolog
administr
inhibitor
colonystimul
factor
receptor
microglia
immun
cell
cn
express
microgli
develop
surviv
highli
depend
signal
chitu
et
al
han
et
al
contrast
liposom
clodron
microinject
select
anatom
region
brain
use
select
deplet
microglia
within
region
torr
et
al
recent
specif
inhibitor
colonystimul
factor
administ
dietari
continu
deplet
microglia
two
studi
viral
enceph
studi
microglia
found
neuroprotect
role
waltl
et
al
wheeler
et
al
final
zebrafish
emerg
model
studi
function
develop
microglia
lyon
talbot
appropri
model
avail
relev
marker
crucial
advanc
understand
microgliapathogen
interplay
anim
model
proven
use
studi
pathogenesi
bacteri
mening
identifi
evalu
potenti
novel
therapeut
target
inher
complex
microglia
reflect
heterogen
activ
state
demand
care
consider
choicecombin
marker
model
monitor
physiolog
pathophysiolog
respons
multitask
cell
type
variou
antiinflammatori
block
agent
prophylact
stimul
target
relev
signal
event
summar
figur
shown
promis
result
promot
surviv
prevent
injuri
experiment
bacteri
mening
inhibit
deleteri
function
microglia
associ
classic
activ
phenotyp
repres
attract
option
adjuv
therapi
antimicrobi
barichello
et
al
enhanc
neuroprotect
function
homeostat
altern
activ
phenotyp
microglia
explor
therapeut
option
mani
neurolog
diseas
includ
bacteri
mening
cherri
et
al
barichello
et
al
chen
trapp
sever
strategi
skew
inflammatori
respons
toward
antiinflammatori
function
appli
experiment
set
rodent
cell
cultur
vitro
also
clinic
case
corticosteroid
glycerol
gerber
nau
efficaci
adjuv
corticosteroid
treatment
debat
proven
benefici
adult
patient
pneumococc
mening
highincom
countri
liechti
et
al
antiinflammatori
cytokin
shown
inhibit
product
inflammatori
cytokin
microglia
astrocyt
isol
mice
previous
challeng
gramneg
bacteria
borrelia
burgdorferi
n
meningitidi
inject
cerebroventricular
space
rasley
et
al
induct
microglia
phenotyp
depend
signal
propos
activ
astrocyt
act
sourc
presenc
turn
attenu
proinflammatori
cytokin
product
microglia
upregul
antiinflammatori
mediat
zhou
et
al
norden
et
al
recent
therapeut
effect
administr
evalu
context
hemorrhag
stroke
inject
directli
brain
mice
induc
intracerebr
hemorrhag
microgli
respons
record
microglia
show
overal
dampen
inflammatori
profil
treat
mice
underw
quicker
function
recoveri
effect
observ
stroke
patient
wherea
initi
increas
plasma
concentr
indic
improv
clinic
outcom
taylor
et
al
could
therefor
strong
candid
futur
therapeut
agent
treatment
acut
brain
injuri
includ
bacteri
mening
howev
sinc
activ
postul
role
hydrocephalu
develop
induct
subarachnoid
fibrosi
approach
may
hold
drawback
botfield
et
al
microglia
express
prr
abl
recogn
bacteri
product
includ
tlr
nodlik
receptor
nlr
member
nlr
famili
shown
crucial
propag
inflamm
respons
gramposit
gramneg
bacteria
liu
et
al
studi
extens
experiment
bacteri
mening
prophylact
stimul
receptor
result
increas
phagocyt
uptak
intracellular
kill
pneumonia
e
coli
microglia
ribe
et
al
inhibit
tlr
signal
also
explor
small
molecul
drug
ibrutinib
tyrosin
kinas
inhibitor
shown
regul
signal
microglia
dampen
lp
induc
proinflammatori
respons
nam
et
al
protein
tyrosin
kinas
inhibitor
reduc
diseas
sever
induc
pneumococc
cell
wall
similar
way
block
leukocyt
influx
brain
product
hanisch
et
al
one
promis
novel
therapeut
approach
tlr
stimul
combin
receptor
agonist
treat
compound
primari
microglia
cell
shown
increas
phagocyt
capac
clear
e
coli
without
increas
releas
proinflammatori
cytokin
affect
cell
viabil
diesselberg
et
al
role
endogen
receptor
tachykinin
substanc
p
neurokinin
receptor
recent
describ
potent
propag
neuroinflamm
neurotox
receptor
antagonist
use
antidepress
antiemet
drug
brain
cox
upon
challeng
pneumonia
mice
administr
receptor
antagonist
led
reduc
inflamm
increas
protect
brain
burmeist
et
al
distinct
activ
associ
neuroprotect
induct
brainderiv
neurotroph
factor
bdnf
ginsenosid
bioactiv
molecul
deriv
ginseng
plant
work
agonist
ginsenosid
treatment
mice
experiment
mening
rescu
tissu
damag
extent
greater
effect
femal
mice
lee
et
al
protect
properti
signal
er
might
explain
gender
bia
cognit
impair
persist
bacteri
mening
male
sex
risk
factor
hoogman
et
al
stimul
phagocyt
function
microglia
could
help
clear
brain
bacteria
quicker
way
resolv
inflamm
palmitoylethanomid
pea
endogen
lipid
shown
antiinflammatori
effect
variou
immun
cell
experiment
meningoenceph
sepsi
induc
e
coli
mice
pretreat
pea
result
improv
surviv
microglia
macrophag
prestimul
pea
vitro
show
dosedepend
higher
uptak
intracellular
kill
e
coli
bacteria
redlich
et
al
pea
recent
shown
mediat
effect
microgli
activ
via
endocannabinoid
system
promot
express
microglia
guida
et
al
sever
experiment
therapeut
intervent
aim
protect
integr
bbb
limit
leukocyt
invas
brain
thu
prevent
excess
microgli
respons
liechti
et
al
includ
pharmacolog
inhibit
mmp
particular
elev
csf
mening
patient
implic
bbb
breakdown
associ
neurolog
sequela
bacteri
mening
mmp
inhibit
sometim
combin
inhibitor
neuroprotect
effect
rat
model
experiment
bacteri
mening
grandgirard
leib
cytokin
mainli
express
damag
neuron
cn
bind
receptor
microglia
recent
found
upregul
tight
junction
brain
endotheli
cell
well
jin
et
al
recent
propos
blockad
bbb
endotheli
receptor
pigr
pneumococcu
use
invad
brain
could
novel
therapeut
approach
mice
treat
block
antibodi
combin
ceftriaxon
antibiot
reach
surviv
rate
day
surviv
studi
also
character
attenu
microgli
activ
iovino
et
al
leukocyt
traffick
brain
contribut
destruct
bbb
recruit
neutrophil
contribut
elev
mmp
level
block
chemotaxi
immun
cell
brain
therefor
suggest
applic
prevent
brain
injuri
howev
surviv
rat
experiment
pneumococc
mening
treat
fucoidin
inhibitor
leukocyt
roll
compromis
reflect
elev
bacteri
load
blood
inabl
clear
infect
brandt
et
al
recent
adjuv
granulocyt
colonystimul
factor
gcsf
therapi
increas
number
neutrophil
circul
shown
posit
effect
spatial
learn
neurogenesi
mice
experiment
pneumococc
mening
gcsf
treatment
effect
microglia
astrocyt
activ
schmidt
et
al
case
gramposit
pneumonia
polysaccharid
capsul
one
potent
activ
microgli
proinflammatori
respons
via
ppr
signal
fact
administr
cell
wall
enough
gener
cn
inflamm
mice
tuomanen
et
al
capsul
confer
protect
kill
immun
system
microglia
encapsul
bacteria
phagocyt
resist
intracellular
kill
intracellular
pneumococci
found
upregul
capsular
gene
fuse
phagolysosom
peppoloni
et
al
pneumococc
surfac
protein
pspa
novel
shown
involv
protect
bacteria
intracellular
kill
use
mutant
strain
peppoloni
et
al
ricci
et
al
anoth
major
pneumococc
virul
factor
pneumolysin
associ
neuron
microgli
cell
death
braun
et
al
pneumonia
found
induc
pyroptosi
microgli
cell
pneumolysin
depend
manner
partial
counteract
increas
express
autophagi
relat
gene
kim
et
al
current
standard
treatment
pneumococc
mening
ceftriaxon
cephalosporin
antibiot
belong
famili
antibiot
induc
lysi
bacteria
lead
releas
bacteri
compon
pneumolysin
pneumococc
cell
wall
turn
augment
microgli
activ
neuroinflamm
use
potent
bactericid
nonbacteriolyt
antibiot
could
therefor
protect
brain
immun
activ
prevent
neurolog
damag
koedel
et
al
liechti
et
al
exampl
agent
daptomycin
evalu
rabbit
infant
rat
experiment
model
pneumococc
mening
found
favor
characterist
bacteri
kill
effici
attenu
neuroinflamm
stucki
et
al
grandgirard
et
al
howev
sinc
daptomycin
cross
outer
membran
gramneg
bacteria
bactericid
activ
restrict
gramposit
bacteria
randal
et
al
anoth
antibiot
may
applic
adjuv
mening
therapi
tetracyclin
antibiot
minocyclin
shown
antiinflammatori
neuroprotect
properti
rat
challeng
lp
proposedli
via
inhibit
microgli
activ
zhu
et
al
two
recent
studi
explor
therapeut
advantag
use
nonbacteriolyt
antibiot
combin
mmp
inhibitor
adjunct
ceftriaxon
treatment
combin
anticompl
studi
report
improv
neurofunct
outcom
mice
rat
experiment
pneumococc
mening
muri
et
al
klein
et
al
mani
factor
affect
select
antimicrobi
therapi
bacteri
mening
type
pathogen
respect
bacteriostaticbactericid
effici
bbb
penetr
antibiot
resist
perspect
recent
notion
releas
bacteri
compon
neural
environ
activ
microglia
potenti
neuroinflamm
like
affect
futur
therapeut
regimen
bacteri
mening
henc
import
aspect
pathophysiolog
bacteri
mening
consid
screen
novel
treatment
approach
revisit
older
one
like
minocyclin
whitbi
finch
taken
togeth
grow
bodi
evid
implic
microglia
central
player
pathogenesi
resolut
bacteri
mening
high
mortal
morbid
rate
immin
emerg
antimicrobi
resist
case
highlight
need
identifi
evalu
novel
therapeut
target
employ
improv
diseas
model
new
tool
studi
dynam
microgli
respons
across
divers
patholog
condit
repres
great
advantag
futur
studi
increas
knowledg
pathophysiolog
bacteri
mening
bacteri
host
factor
involv
certainli
contribut
goal
improv
prevent
therapeut
approach
manag
bacteri
mening
st
fi
wrote
literatur
studi
wrote
manuscript
bhn
contribut
write
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
